Credit Suisse Group AG (ADR) (CS) reported quarterly earnings results on Tuesday, May-10-2016. The company reported $-0.15 earnings per share for the quarter, missing the analyst consensus estimate by $-0.07. Analysts had a consensus of $-0.08. The company posted revenue of $4750.00 million in the period, compared to analysts expectations of $5014.60 million. The company’s revenue was down -26.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.
Many Wall Street Analysts have commented on Credit Suisse Group AG (ADR). Credit Suisse Group AG (ADR) was Downgraded by Exane BNP Paribas to ” Underperform” on Apr 5, 2016. Credit Suisse Group AG (ADR) was Upgraded by Macquarie to ” Outperform” on Feb 23, 2016. Credit Suisse Group AG (ADR) was Downgraded by JP Morgan to ” Neutral” on Feb 16, 2016.
Credit Suisse Group AG (ADR) closed down -0.09 points or -0.64% at $14 with 51,98,304 shares getting traded on Friday. Post opening the session at $13.62, the shares hit an intraday low of $13.62 and an intraday high of $14.01 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Credit Suisse Group AG (Credit Suisse) is a global financial services company. The Company operates in three segments: Private Banking & Wealth Management and Investment Banking. Private Banking & Wealth Management offers advice and a range of financial solutions to private corporate and institutional clients. The Private Banking & Wealth Management comprises the Wealth Management Clients Corporate & Institutional Clients and Asset Management businesses. Asset Management offers a range of investment products and solutions across asset classes and for all investment styles serving governments institutions corporations and individuals across the world. Investment Banking offers investment banking and securities products and services to corporate institutional and government clients around the world. Its products and services include debt and equity underwriting sales and trading M&A advice divestitures corporate sales restructuring and investment research.